DNA sequencing Market by Product (Consumable, Instrument, and Service) Application (Biomarkers and Cancer, Diagnostics, Reproductive Health, Personalized Medicine, Forensics, and Other Applications), Technology (Sequencing by Synthesis, Ion Semiconductor Sequencing, Sequencing by Ligation, Pyrosequencing, Single Molecule Real-Time Sequencing, Chain Termination Sequencing, and Nanopore Sequencing), and End User (Academic & Government Research Institutes, Pharmaceutical Companies, Biotechnology Companies, and Hospitals & Clinics): Global Opportunity Analysis and Industry Forecast, 2017 - 2025
DNA Sequencing Market Overview:
DNA sequencing is a molecular technique that helps determine the nucleotide sequence of DNA (deoxyribonucleic acid), which is the most fundamental level of knowledge of a gene or genome. The global DNA sequencing market accounted for $6,243 million in 2017, and is anticipated to reach $25,470 million by 2025, registering a CAGR of 19.0% from 2017 to 2025. DNA sequencing has revolutionized molecular biology and genomics research. The knowledge of DNA sequences of genes and other parts of the genome of organisms has become essential for life-science research and also in applied fields, such as forensics, cancer diagnostics, and others. Through this method, billions of DNA strands can be sequenced efficiently. DNA sequencing has made it possible to conveniently sequence whole genomes and analyze various DNA-protein interactions. This technique allows the researcher to focus, study, and interpret deep sequence target regions. They are utilized through varied interventions, such as oncology, biomarker studies, drug discovery, understanding reproductive health, and personalized genomics.
Technological advancements in sequencing equipment, surge in applications of DNA sequencing, and increase in genome mapping programs drive the global DNA sequencing market. In addition, rise in awareness pertaining to DNA sequencing and increase in investment in research, development, and innovation supplement the market growth. However, lack of skilled professionals, ethical & legal limitations related to DNA sequencing, and standardization concerns in sequencing procedures impede the market growth. Furthermore, use of cloud computing as a potential data management service and the untapped emerging countries offer lucrative opportunities for the market players.
The DNA sequencing market is segmented based on product, application, technology, end user, and geography. Based on product, it is categorized into consumable, instrument, and service. The consumables segment accounted for a dominant share in 2017 and is expected to maintain this trend during the forecast period. This is attributed to the fact that they are widely used throughout the sample preparation process and other pre-requisite steps of DNA sequencing.
Based on application, it is categorized into biomarkers & cancer, diagnostics, reproductive health, personalized medicine, forensics, and other applications. The biomarkers & cancer application was the highest revenue contributor in 2017, while the personalized medicine segment is anticipated to grow at the highest rate. The growth for this segment is due to increase in investment in R&D globally and surge in awareness about DNA sequencing applications in precision medicine. Based on technology, the DNA sequencing technology market is classified into sequencing by synthesis, ion semiconductor sequencing, sequencing by ligation, pyrosequencing, single molecule real-time sequencing, chain termination sequencing, and nanopore sequencing technologies. The sequencing by synthesis technology segment accounted for the highest share in 2017 and is estimated to continue this trend throughout the study period as this technology allows both short and long insert paired end reads for high resolution genome sequencing, structural variation detection, sequence assembly, and others.
Based on region, this market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. North America accounted for the highest market share in the DNA sequencing market in 2017 and is expected to maintain its dominance throughout the forecast period. This is primarily attributed to the higher buying power, availability, and applications that favor the utilization of DNA sequencing. There is also an increase in agreements and collaborations between different market players and health centers to promote and utilize DNA sequencing in this region. However, Asia-Pacific is expected to emerge as a lucrative area with maximum growth potential, owing to the improvement in R&D facilities, rise in disposable income, and rapidly development in economic conditions.
Key Benefits for DNA sequencing Market:
By Product
DNA sequencing is a molecular technique that helps determine the nucleotide sequence of DNA (deoxyribonucleic acid), which is the most fundamental level of knowledge of a gene or genome. The global DNA sequencing market accounted for $6,243 million in 2017, and is anticipated to reach $25,470 million by 2025, registering a CAGR of 19.0% from 2017 to 2025. DNA sequencing has revolutionized molecular biology and genomics research. The knowledge of DNA sequences of genes and other parts of the genome of organisms has become essential for life-science research and also in applied fields, such as forensics, cancer diagnostics, and others. Through this method, billions of DNA strands can be sequenced efficiently. DNA sequencing has made it possible to conveniently sequence whole genomes and analyze various DNA-protein interactions. This technique allows the researcher to focus, study, and interpret deep sequence target regions. They are utilized through varied interventions, such as oncology, biomarker studies, drug discovery, understanding reproductive health, and personalized genomics.
Technological advancements in sequencing equipment, surge in applications of DNA sequencing, and increase in genome mapping programs drive the global DNA sequencing market. In addition, rise in awareness pertaining to DNA sequencing and increase in investment in research, development, and innovation supplement the market growth. However, lack of skilled professionals, ethical & legal limitations related to DNA sequencing, and standardization concerns in sequencing procedures impede the market growth. Furthermore, use of cloud computing as a potential data management service and the untapped emerging countries offer lucrative opportunities for the market players.
The DNA sequencing market is segmented based on product, application, technology, end user, and geography. Based on product, it is categorized into consumable, instrument, and service. The consumables segment accounted for a dominant share in 2017 and is expected to maintain this trend during the forecast period. This is attributed to the fact that they are widely used throughout the sample preparation process and other pre-requisite steps of DNA sequencing.
Based on application, it is categorized into biomarkers & cancer, diagnostics, reproductive health, personalized medicine, forensics, and other applications. The biomarkers & cancer application was the highest revenue contributor in 2017, while the personalized medicine segment is anticipated to grow at the highest rate. The growth for this segment is due to increase in investment in R&D globally and surge in awareness about DNA sequencing applications in precision medicine. Based on technology, the DNA sequencing technology market is classified into sequencing by synthesis, ion semiconductor sequencing, sequencing by ligation, pyrosequencing, single molecule real-time sequencing, chain termination sequencing, and nanopore sequencing technologies. The sequencing by synthesis technology segment accounted for the highest share in 2017 and is estimated to continue this trend throughout the study period as this technology allows both short and long insert paired end reads for high resolution genome sequencing, structural variation detection, sequence assembly, and others.
Based on region, this market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. North America accounted for the highest market share in the DNA sequencing market in 2017 and is expected to maintain its dominance throughout the forecast period. This is primarily attributed to the higher buying power, availability, and applications that favor the utilization of DNA sequencing. There is also an increase in agreements and collaborations between different market players and health centers to promote and utilize DNA sequencing in this region. However, Asia-Pacific is expected to emerge as a lucrative area with maximum growth potential, owing to the improvement in R&D facilities, rise in disposable income, and rapidly development in economic conditions.
Key Benefits for DNA sequencing Market:
- The study provides an in-depth analysis of the global DNA sequencing market and the current trends and future estimations to elucidate the imminent investment pockets.
- The report presents quantitative analysis of the market from 2017 to 2025 to enable the stakeholders to capitalize on the prevailing market opportunities.
- Extensive analysis of the market based on product assists to understand the trends in the industry.
- Key market players and their strategies are thoroughly analyzed to understand the competitive outlook of the industry
By Product
- Consumable
- Instrument
- Service
- Diagnostics
- Biomarkers and Cancer
- Reproductive Health
- Personalized Medicine
- Forensics
- Other Applications
- Sequencing by Synthesis
- Ion Semiconductor Sequencing
- Sequencing by Ligation
- Pyrosequencing
- Single Molecule Real-Time Sequencing
- Chain Termination Sequencing
- Nanopore Sequencing
- Academic & Government Research Institutes
- Pharmaceutical Companies
- Biotechnology Companies
- Hospitals & Clinics
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- Australia
- India
- South Korea
- Taiwan
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Turkey
- Saudi Arabia
- Rest of LAMEA
- Abbott Laboratories
- Agilent Technologies, Inc.
- Danaher Corporation (Beckman Coulter, Inc.)
- F. Hoffmann-La Roche Ltd
- Illumina, Inc
- LI-COR Biosciences, Inc.
- Pacific Biosciences of California, Inc.
- SIEMENS AG; PerkinElmer Inc.
- Thermo Fisher Scientific, Inc.
CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.3.1. List of key players profiled in the report
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.2. CXO perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.3. Top winning strategies
3.4. Market share analysis
3.4.1. Overview
3.5. Patents analysis
3.5.1. Patent analysis, by region
3.5.2. Patent analysis, by year
3.6. Porters five forces analysis
3.7. Market dynamics
3.7.1. Drivers
3.7.1.1. Technological advancements in DNA sequencing
3.7.1.2. Surge in applications of DNA sequencing
3.7.1.3. Increase in partnerships and collaborations
3.7.1.4. Increase in genome mapping programs
3.7.2. Restraints
3.7.2.1. Standardization concerns over DNA sequencing-based diagnostics
3.7.2.2. Dearth of skilled professionals
3.7.2.3. Ethical and legal limitations
3.7.3. Opportunities
3.7.3.1. Lucrative opportunities in emerging markets
3.7.3.2. Cloud computing as a potential data management service
3.7.4. Impact analyses
CHAPTER 4: DNA SEQUENCING MARKET, BY PRODUCT
4.1. Overview
4.1.1. Market size and forecast
4.2. Consumables
4.2.1. Key market trends, growth factors, and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market analysis, by country
4.3. Instruments
4.3.1. Key market trends, growth factors, and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market analysis, by country
4.4. Services
4.4.1. Key market trends, growth factors, and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market analysis, by country
CHAPTER 5: DNA SEQUENCING MARKET, BY APPLICATION
5.1. Overview
5.1.1. Market size and forecast
5.2. Biomarker & cancer
5.2.1. Market size and forecast, by region
5.2.2. Market share analysis
5.3. Diagnostics
5.3.1. Market size and forecast, by region
5.3.2. Market share analysis, by country
5.4. Reproductive health
5.4.1. Market size and forecast, by region
5.4.2. Market share analysis, by country
5.5. Personalized medicine
5.5.1. Market size and forecast, by region
5.5.2. Market share analysis, by country
5.6. Forensics
5.6.1. Market size and forecast, by region
5.6.2. Market share analysis
5.7. Others
5.7.1. Market size and forecast, by region
5.7.2. Market share analysis
CHAPTER 6: DNA SEQUENCING MARKET, BY TECHNOLOGY
6.1. Overview
6.1.1. Market size and forecast
6.2. Sequencing by synthesis
6.2.1. Market size and forecast, by region
6.2.2. Market analysis, by country
6.3. Ion semiconductor sequencing
6.3.1. Market size and forecast, by region
6.3.2. Market share analysis, by country
6.4. Sequencing by ligation
6.4.1. Market size and forecast, by region
6.4.2. Market share analysis, by country
6.5. Pyrosequencing
6.5.1. Market size and forecast, by region
6.5.2. Market share analysis, by country
6.6. Single-molecule real-time sequencing
6.6.1. Market size and forecast, by region
6.6.2. Market share analysis, by country
6.7. Chain termination technology
6.7.1. Market size and forecast, by region
6.7.2. Market share analysis, by country
6.8. Nanopore sequencing
6.8.1. Market size and forecast, by region
6.8.2. Market share analysis, by country
CHAPTER 7: DNA SEQUENCING MARKET, BY END USER
7.1. Overview
7.1.1. Market size and forecast
7.2. Academic & government research institute
7.2.1. Market size and forecast, by region
7.2.2. Market share analysis, by country
7.3. Pharmaceutical companies
7.3.1. Market size and forecast, by region
7.3.2. Market share analysis, by country
7.4. Biotechnology companies
7.4.1. Market size and forecast, by region
7.4.2. Market share analysis
7.5. Hospital & clinics
7.5.1. Market size and forecast, by region
7.5.2. Market share analysis
CHAPTER 8: DNA SEQUENCING MARKET, BY REGION
8.1. Overview
8.1.1. Market size and forecast
8.2. North America
8.2.1. Key market trends, growth factors, and opportunities
8.2.2. Market size and forecast, by country
8.2.2.1. U.S.
8.2.2.1.1. U.S. DNA sequencing market, by product
8.2.2.1.2. U.S. DNA sequencing market, by application
8.2.2.1.3. U.S. DNA sequencing market, by technology
8.2.2.1.4. U.S. DNA sequencing market, by end user
8.2.2.2. Canada
8.2.2.2.1. Canada DNA sequencing market, by product
8.2.2.2.2. Canada DNA sequencing market, by application
8.2.2.2.3. Canada DNA sequencing market, by technology
8.2.2.2.4. Canada DNA sequencing market, by end user
8.2.2.3. Mexico
8.2.2.3.1. Mexico DNA sequencing market, by product
8.2.2.3.2. Mexico DNA sequencing market, by application
8.2.2.3.3. Mexico DNA sequencing market, by technology
8.2.2.3.4. Mexico DNA sequencing market, by end user
8.2.3. Market size and forecast, by product
8.2.4. Market size and forecast, by application
8.2.5. Market size and forecast, by technology
8.2.6. Market size and forecast, by end user
8.3. Europe
8.3.1. Key market trends, growth factors, and opportunities
8.3.2. Market size and forecast, by country
8.3.2.1. Germany
8.3.2.1.1. Germany DNA sequencing market, by product
8.3.2.1.2. Germany DNA sequencing market, by application
8.3.2.1.3. Germany DNA sequencing market, by technology
8.3.2.1.4. Germany DNA sequencing market, by end user
8.3.2.2. France
8.3.2.2.1. France DNA sequencing market, by product
8.3.2.2.2. France DNA sequencing market, by application
8.3.2.2.3. France DNA sequencing market, by technology
8.3.2.2.4. France DNA sequencing market, by end user
8.3.2.3. UK
8.3.2.3.1. UK DNA sequencing market, by product
8.3.2.3.2. UK DNA sequencing market, by application
8.3.2.3.3. UK DNA sequencing market, by technology
8.3.2.3.4. UK DNA sequencing market, by end user
8.3.2.4. Italy
8.3.2.4.1. Italy DNA sequencing market, by product
8.3.2.4.2. Italy DNA sequencing market, by application
8.3.2.4.3. Italy DNA sequencing market, by technology
8.3.2.4.4. Italy DNA sequencing market, by end user
8.3.2.5. Spain
8.3.2.5.1. Spain DNA sequencing market, by product
8.3.2.5.2. Spain DNA sequencing market, by application
8.3.2.5.3. Spain DNA sequencing market, by technology
8.3.2.5.4. Spain DNA sequencing market, by end user
8.3.2.6. Rest of Europe
8.3.2.6.1. Rest of Europe DNA sequencing market, by product
8.3.2.6.2. Rest of Europe DNA sequencing market, by application
8.3.2.6.3. Rest of Europe DNA sequencing market, by technology
8.3.2.6.4. Rest of Europe DNA sequencing market, by end user
8.3.3. Market size and forecast, by product
8.3.4. Market size and forecast, by application
8.3.5. Market size and forecast, by technology
8.3.6. Market size and forecast, by end user
8.4. Asia-Pacific
8.4.1. Key market trends, growth factors, and opportunities
8.4.2. Market size and forecast, by country
8.4.2.1. Japan
8.4.2.1.1. Japan DNA sequencing market, by product
8.4.2.1.2. Japan DNA sequencing market, by application
8.4.2.1.3. Japan DNA sequencing market, by technology
8.4.2.1.4. Japan DNA sequencing market, by end user
8.4.2.2. China
8.4.2.2.1. China DNA sequencing market, by product
8.4.2.2.2. China DNA sequencing market, by application
8.4.2.2.3. China DNA sequencing market, by technology
8.4.2.2.4. China DNA sequencing market, by end user
8.4.2.3. Australia
8.4.2.3.1. Australia DNA sequencing market, by product
8.4.2.3.2. Australia DNA sequencing market, by application
8.4.2.3.3. Australia DNA sequencing market, by technology
8.4.2.3.4. Australia DNA sequencing market, by end user
8.4.2.4. India
8.4.2.4.1. India DNA sequencing market, by product
8.4.2.4.2. India DNA sequencing market, by application
8.4.2.4.3. India DNA sequencing market, by technology
8.4.2.4.4. India DNA sequencing market, by end user
8.4.2.5. South Korea
8.4.2.5.1. South Korea DNA sequencing market, by product
8.4.2.5.2. South Korea DNA sequencing market, by application
8.4.2.5.3. South Korea DNA sequencing market, by technology
8.4.2.5.4. South Korea DNA sequencing market, by end user
8.4.2.6. Taiwan
8.4.2.6.1. Taiwan DNA sequencing market, by product
8.4.2.6.2. Taiwan DNA sequencing market, by application
8.4.2.6.3. Taiwan DNA sequencing market, by technology
8.4.2.6.4. Taiwan DNA sequencing market, by end user
8.4.2.7. Rest of Asia-Pacific
8.4.2.7.1. Rest of Asia-Pacific DNA sequencing market, by product
8.4.2.7.2. Rest of Asia-Pacific DNA sequencing market, by application
8.4.2.7.3. Rest of Asia-Pacific DNA sequencing market, by technology
8.4.2.7.4. Rest of Asia-Pacific DNA sequencing market, by end user
8.4.3. Market size and forecast, by product
8.4.4. Market size and forecast, by application
8.4.5. Market size and forecast, by technology
8.4.6. Market size and forecast, by end user
8.5. LAMEA
8.5.1. Key market trends, growth factors, and opportunities
8.5.2. Market size and forecast, by country
8.5.2.1. Brazil
8.5.2.1.1. Brazil DNA sequencing market, by product
8.5.2.1.2. Brazil DNA sequencing market, by application
8.5.2.1.3. Brazil DNA sequencing market, by technology
8.5.2.1.4. Brazil DNA sequencing market, by end user
8.5.2.2. Turkey
8.5.2.2.1. Turkey DNA sequencing market, by product
8.5.2.2.2. Turkey DNA sequencing market, by application
8.5.2.2.3. Turkey DNA sequencing market, by technology
8.5.2.2.4. Turkey DNA sequencing market, by end user
8.5.2.3. Saudi Arabia
8.5.2.3.1. Saudi Arabia DNA sequencing market, by product
8.5.2.3.2. Saudi Arabia DNA sequencing market, by application
8.5.2.3.3. Saudi Arabia DNA sequencing market, by technology
8.5.2.3.4. Saudi Arabia DNA sequencing market, by end user
8.5.2.4. Rest of LAMEA
8.5.2.4.1. Rest of LAMEA DNA sequencing market, by product
8.5.2.4.2. Rest of LAMEA DNA sequencing market, by application
8.5.2.4.3. Rest of LAMEA DNA sequencing market, by technology
8.5.2.4.4. Rest of LAMEA DNA sequencing market, by end user
8.5.3. Market size and forecast, by product
8.5.4. Market size and forecast, by application
8.5.5. Market size and forecast, by technology
8.5.6. Market size and forecast, by end user
CHAPTER 9: COMPANY PROFILES
9.1. ABBOTT LABORATORIES
9.1.1. Company overview
9.1.2. Company snapshot
9.1.3. Operating business segments
9.1.4. Product portfolio
9.1.5. Business performance
9.2. AGILENT TECHNOLOGIES, INC.
9.2.1. Company overview
9.2.2. Company snapshot
9.2.3. Operating business segments
9.2.4. Product portfolio
9.2.5. Business performance
9.2.6. Key strategic moves and developments
9.3. DANAHER CORPORATION (BECKMAN COULTER, INC.)
9.3.1. Company overview
9.3.2. Company snapshot
9.3.3. Operating business segments
9.3.4. Product portfolio
9.3.5. Business performance
9.4. F. HOFFMANN-LA ROCHE LTD.
9.4.1. Company overview
9.4.2. Company snapshot
9.4.3. Operating business segments
9.4.4. Product portfolio
9.4.5. Business performance
9.4.6. Key strategic moves and developments
9.5. ILLUMINA, INC.
9.5.1. Company overview
9.5.2. Company snapshot
9.5.3. Operating business segments
9.5.4. Product Portfolio
9.5.5. Business performance
9.5.6. Key strategic moves and developments
9.6. LI-COR, INC.
9.6.1. Company overview
9.6.2. Company snapshot
9.6.3. Operating business segments
9.6.4. Product portfolio
9.7. PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
9.7.1. Company overview
9.7.2. Company snapshot
9.7.3. Operating business segments
9.7.4. Product portfolio
9.7.5. Business performance
9.7.6. Key strategic moves and developments
9.8. PERKINELMER INC.
9.8.1. Company overview
9.8.2. Company snapshot
9.8.3. Operating business segments
9.8.4. Product Portfolio
9.8.5. Business performance
9.9. SIEMENS AG
9.9.1. Company overview
9.9.2. Company snapshot
9.9.3. Operating business segments
9.9.4. Product portfolio
9.9.5. Business performance
9.10. THERMO FISHER SCIENTIFIC, INC.
9.10.1. Company overview
9.10.2. Company snapshot
9.10.3. Operating business segments
9.10.4. Product portfolio
9.10.5. Business performance
9.10.6. Key strategic moves and developments
1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.3.1. List of key players profiled in the report
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.2. CXO perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.3. Top winning strategies
3.4. Market share analysis
3.4.1. Overview
3.5. Patents analysis
3.5.1. Patent analysis, by region
3.5.2. Patent analysis, by year
3.6. Porters five forces analysis
3.7. Market dynamics
3.7.1. Drivers
3.7.1.1. Technological advancements in DNA sequencing
3.7.1.2. Surge in applications of DNA sequencing
3.7.1.3. Increase in partnerships and collaborations
3.7.1.4. Increase in genome mapping programs
3.7.2. Restraints
3.7.2.1. Standardization concerns over DNA sequencing-based diagnostics
3.7.2.2. Dearth of skilled professionals
3.7.2.3. Ethical and legal limitations
3.7.3. Opportunities
3.7.3.1. Lucrative opportunities in emerging markets
3.7.3.2. Cloud computing as a potential data management service
3.7.4. Impact analyses
CHAPTER 4: DNA SEQUENCING MARKET, BY PRODUCT
4.1. Overview
4.1.1. Market size and forecast
4.2. Consumables
4.2.1. Key market trends, growth factors, and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market analysis, by country
4.3. Instruments
4.3.1. Key market trends, growth factors, and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market analysis, by country
4.4. Services
4.4.1. Key market trends, growth factors, and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market analysis, by country
CHAPTER 5: DNA SEQUENCING MARKET, BY APPLICATION
5.1. Overview
5.1.1. Market size and forecast
5.2. Biomarker & cancer
5.2.1. Market size and forecast, by region
5.2.2. Market share analysis
5.3. Diagnostics
5.3.1. Market size and forecast, by region
5.3.2. Market share analysis, by country
5.4. Reproductive health
5.4.1. Market size and forecast, by region
5.4.2. Market share analysis, by country
5.5. Personalized medicine
5.5.1. Market size and forecast, by region
5.5.2. Market share analysis, by country
5.6. Forensics
5.6.1. Market size and forecast, by region
5.6.2. Market share analysis
5.7. Others
5.7.1. Market size and forecast, by region
5.7.2. Market share analysis
CHAPTER 6: DNA SEQUENCING MARKET, BY TECHNOLOGY
6.1. Overview
6.1.1. Market size and forecast
6.2. Sequencing by synthesis
6.2.1. Market size and forecast, by region
6.2.2. Market analysis, by country
6.3. Ion semiconductor sequencing
6.3.1. Market size and forecast, by region
6.3.2. Market share analysis, by country
6.4. Sequencing by ligation
6.4.1. Market size and forecast, by region
6.4.2. Market share analysis, by country
6.5. Pyrosequencing
6.5.1. Market size and forecast, by region
6.5.2. Market share analysis, by country
6.6. Single-molecule real-time sequencing
6.6.1. Market size and forecast, by region
6.6.2. Market share analysis, by country
6.7. Chain termination technology
6.7.1. Market size and forecast, by region
6.7.2. Market share analysis, by country
6.8. Nanopore sequencing
6.8.1. Market size and forecast, by region
6.8.2. Market share analysis, by country
CHAPTER 7: DNA SEQUENCING MARKET, BY END USER
7.1. Overview
7.1.1. Market size and forecast
7.2. Academic & government research institute
7.2.1. Market size and forecast, by region
7.2.2. Market share analysis, by country
7.3. Pharmaceutical companies
7.3.1. Market size and forecast, by region
7.3.2. Market share analysis, by country
7.4. Biotechnology companies
7.4.1. Market size and forecast, by region
7.4.2. Market share analysis
7.5. Hospital & clinics
7.5.1. Market size and forecast, by region
7.5.2. Market share analysis
CHAPTER 8: DNA SEQUENCING MARKET, BY REGION
8.1. Overview
8.1.1. Market size and forecast
8.2. North America
8.2.1. Key market trends, growth factors, and opportunities
8.2.2. Market size and forecast, by country
8.2.2.1. U.S.
8.2.2.1.1. U.S. DNA sequencing market, by product
8.2.2.1.2. U.S. DNA sequencing market, by application
8.2.2.1.3. U.S. DNA sequencing market, by technology
8.2.2.1.4. U.S. DNA sequencing market, by end user
8.2.2.2. Canada
8.2.2.2.1. Canada DNA sequencing market, by product
8.2.2.2.2. Canada DNA sequencing market, by application
8.2.2.2.3. Canada DNA sequencing market, by technology
8.2.2.2.4. Canada DNA sequencing market, by end user
8.2.2.3. Mexico
8.2.2.3.1. Mexico DNA sequencing market, by product
8.2.2.3.2. Mexico DNA sequencing market, by application
8.2.2.3.3. Mexico DNA sequencing market, by technology
8.2.2.3.4. Mexico DNA sequencing market, by end user
8.2.3. Market size and forecast, by product
8.2.4. Market size and forecast, by application
8.2.5. Market size and forecast, by technology
8.2.6. Market size and forecast, by end user
8.3. Europe
8.3.1. Key market trends, growth factors, and opportunities
8.3.2. Market size and forecast, by country
8.3.2.1. Germany
8.3.2.1.1. Germany DNA sequencing market, by product
8.3.2.1.2. Germany DNA sequencing market, by application
8.3.2.1.3. Germany DNA sequencing market, by technology
8.3.2.1.4. Germany DNA sequencing market, by end user
8.3.2.2. France
8.3.2.2.1. France DNA sequencing market, by product
8.3.2.2.2. France DNA sequencing market, by application
8.3.2.2.3. France DNA sequencing market, by technology
8.3.2.2.4. France DNA sequencing market, by end user
8.3.2.3. UK
8.3.2.3.1. UK DNA sequencing market, by product
8.3.2.3.2. UK DNA sequencing market, by application
8.3.2.3.3. UK DNA sequencing market, by technology
8.3.2.3.4. UK DNA sequencing market, by end user
8.3.2.4. Italy
8.3.2.4.1. Italy DNA sequencing market, by product
8.3.2.4.2. Italy DNA sequencing market, by application
8.3.2.4.3. Italy DNA sequencing market, by technology
8.3.2.4.4. Italy DNA sequencing market, by end user
8.3.2.5. Spain
8.3.2.5.1. Spain DNA sequencing market, by product
8.3.2.5.2. Spain DNA sequencing market, by application
8.3.2.5.3. Spain DNA sequencing market, by technology
8.3.2.5.4. Spain DNA sequencing market, by end user
8.3.2.6. Rest of Europe
8.3.2.6.1. Rest of Europe DNA sequencing market, by product
8.3.2.6.2. Rest of Europe DNA sequencing market, by application
8.3.2.6.3. Rest of Europe DNA sequencing market, by technology
8.3.2.6.4. Rest of Europe DNA sequencing market, by end user
8.3.3. Market size and forecast, by product
8.3.4. Market size and forecast, by application
8.3.5. Market size and forecast, by technology
8.3.6. Market size and forecast, by end user
8.4. Asia-Pacific
8.4.1. Key market trends, growth factors, and opportunities
8.4.2. Market size and forecast, by country
8.4.2.1. Japan
8.4.2.1.1. Japan DNA sequencing market, by product
8.4.2.1.2. Japan DNA sequencing market, by application
8.4.2.1.3. Japan DNA sequencing market, by technology
8.4.2.1.4. Japan DNA sequencing market, by end user
8.4.2.2. China
8.4.2.2.1. China DNA sequencing market, by product
8.4.2.2.2. China DNA sequencing market, by application
8.4.2.2.3. China DNA sequencing market, by technology
8.4.2.2.4. China DNA sequencing market, by end user
8.4.2.3. Australia
8.4.2.3.1. Australia DNA sequencing market, by product
8.4.2.3.2. Australia DNA sequencing market, by application
8.4.2.3.3. Australia DNA sequencing market, by technology
8.4.2.3.4. Australia DNA sequencing market, by end user
8.4.2.4. India
8.4.2.4.1. India DNA sequencing market, by product
8.4.2.4.2. India DNA sequencing market, by application
8.4.2.4.3. India DNA sequencing market, by technology
8.4.2.4.4. India DNA sequencing market, by end user
8.4.2.5. South Korea
8.4.2.5.1. South Korea DNA sequencing market, by product
8.4.2.5.2. South Korea DNA sequencing market, by application
8.4.2.5.3. South Korea DNA sequencing market, by technology
8.4.2.5.4. South Korea DNA sequencing market, by end user
8.4.2.6. Taiwan
8.4.2.6.1. Taiwan DNA sequencing market, by product
8.4.2.6.2. Taiwan DNA sequencing market, by application
8.4.2.6.3. Taiwan DNA sequencing market, by technology
8.4.2.6.4. Taiwan DNA sequencing market, by end user
8.4.2.7. Rest of Asia-Pacific
8.4.2.7.1. Rest of Asia-Pacific DNA sequencing market, by product
8.4.2.7.2. Rest of Asia-Pacific DNA sequencing market, by application
8.4.2.7.3. Rest of Asia-Pacific DNA sequencing market, by technology
8.4.2.7.4. Rest of Asia-Pacific DNA sequencing market, by end user
8.4.3. Market size and forecast, by product
8.4.4. Market size and forecast, by application
8.4.5. Market size and forecast, by technology
8.4.6. Market size and forecast, by end user
8.5. LAMEA
8.5.1. Key market trends, growth factors, and opportunities
8.5.2. Market size and forecast, by country
8.5.2.1. Brazil
8.5.2.1.1. Brazil DNA sequencing market, by product
8.5.2.1.2. Brazil DNA sequencing market, by application
8.5.2.1.3. Brazil DNA sequencing market, by technology
8.5.2.1.4. Brazil DNA sequencing market, by end user
8.5.2.2. Turkey
8.5.2.2.1. Turkey DNA sequencing market, by product
8.5.2.2.2. Turkey DNA sequencing market, by application
8.5.2.2.3. Turkey DNA sequencing market, by technology
8.5.2.2.4. Turkey DNA sequencing market, by end user
8.5.2.3. Saudi Arabia
8.5.2.3.1. Saudi Arabia DNA sequencing market, by product
8.5.2.3.2. Saudi Arabia DNA sequencing market, by application
8.5.2.3.3. Saudi Arabia DNA sequencing market, by technology
8.5.2.3.4. Saudi Arabia DNA sequencing market, by end user
8.5.2.4. Rest of LAMEA
8.5.2.4.1. Rest of LAMEA DNA sequencing market, by product
8.5.2.4.2. Rest of LAMEA DNA sequencing market, by application
8.5.2.4.3. Rest of LAMEA DNA sequencing market, by technology
8.5.2.4.4. Rest of LAMEA DNA sequencing market, by end user
8.5.3. Market size and forecast, by product
8.5.4. Market size and forecast, by application
8.5.5. Market size and forecast, by technology
8.5.6. Market size and forecast, by end user
CHAPTER 9: COMPANY PROFILES
9.1. ABBOTT LABORATORIES
9.1.1. Company overview
9.1.2. Company snapshot
9.1.3. Operating business segments
9.1.4. Product portfolio
9.1.5. Business performance
9.2. AGILENT TECHNOLOGIES, INC.
9.2.1. Company overview
9.2.2. Company snapshot
9.2.3. Operating business segments
9.2.4. Product portfolio
9.2.5. Business performance
9.2.6. Key strategic moves and developments
9.3. DANAHER CORPORATION (BECKMAN COULTER, INC.)
9.3.1. Company overview
9.3.2. Company snapshot
9.3.3. Operating business segments
9.3.4. Product portfolio
9.3.5. Business performance
9.4. F. HOFFMANN-LA ROCHE LTD.
9.4.1. Company overview
9.4.2. Company snapshot
9.4.3. Operating business segments
9.4.4. Product portfolio
9.4.5. Business performance
9.4.6. Key strategic moves and developments
9.5. ILLUMINA, INC.
9.5.1. Company overview
9.5.2. Company snapshot
9.5.3. Operating business segments
9.5.4. Product Portfolio
9.5.5. Business performance
9.5.6. Key strategic moves and developments
9.6. LI-COR, INC.
9.6.1. Company overview
9.6.2. Company snapshot
9.6.3. Operating business segments
9.6.4. Product portfolio
9.7. PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
9.7.1. Company overview
9.7.2. Company snapshot
9.7.3. Operating business segments
9.7.4. Product portfolio
9.7.5. Business performance
9.7.6. Key strategic moves and developments
9.8. PERKINELMER INC.
9.8.1. Company overview
9.8.2. Company snapshot
9.8.3. Operating business segments
9.8.4. Product Portfolio
9.8.5. Business performance
9.9. SIEMENS AG
9.9.1. Company overview
9.9.2. Company snapshot
9.9.3. Operating business segments
9.9.4. Product portfolio
9.9.5. Business performance
9.10. THERMO FISHER SCIENTIFIC, INC.
9.10.1. Company overview
9.10.2. Company snapshot
9.10.3. Operating business segments
9.10.4. Product portfolio
9.10.5. Business performance
9.10.6. Key strategic moves and developments
LIST OF TABLES
TABLE 01. GLOBAL DNA SEQUENCING MARKET, BY PRODUCT, 20172025 ($MILLION)
TABLE 02. DNA SEQUENCING MARKET FOR CONSUMABLES, BY REGION, 20162023 ($MILLION)
TABLE 03. DNA SEQUENCING MARKET FOR INSTRUMENTS, BY REGION, 20172025 ($MILLION)
TABLE 04. DNA SEQUENCING MARKET FOR SERVICES, BY REGION, 20172025 ($MILLION)
TABLE 05. GLOBAL DNA SEQUENCING MARKET, BY INDICATION, 20172025 ($MILLION)
TABLE 06. DNA SEQUENCING MARKET FOR BIOMARKER AND CANCER, BY REGION, 20172025 ($MILLION)
TABLE 07. DNA SEQUENCING MARKET FOR DIAGNOSTICS, BY REGION, 20172025 ($MILLION)
TABLE 08. DNA SEQUENCING MARKET FOR REPRODUCTIVE HEALTH, BY REGION, 20172025 ($MILLION)
TABLE 09. DNA SEQUENCING MARKET FOR PERSONALIZED MEDICINE, BY REGION, 20172025 ($MILLION)
TABLE 10. DNA SEQUENCING MARKET FOR FORENSICS, BY REGION, 20172025 ($MILLION)
TABLE 11. DNA SEQUENCING MARKET FOR OTHER APPLICATIONS, BY REGION, 20172025 ($MILLION)
TABLE 12. GLOBAL DNA SEQUENCING MARKET, BY TECHNOLOGY, 20172025 ($MILLION)
TABLE 13. DNA SEQUENCING MARKET FOR SEQUENCING BY SYNTHESIS, BY REGION, 20172025 ($MILLION)
TABLE 14. DNA SEQUENCING MARKET FOR ION SEMICONDUCTOR SEQUENCING, BY REGION, 20172025 ($MILLION)
TABLE 15. DNA SEQUENCING MARKET FOR SEQUENCING BY LIGATION, BY REGION, 20172025 ($MILLION)
TABLE 16. DNA SEQUENCING MARKET FOR PYROSEQUENCING, BY REGION, 20172025 ($MILLION)
TABLE 17. DNA SEQUENCING MARKET FOR SINGLE-MOLECULE REAL-TIME SEQUENCING, BY REGION, 20172025 ($MILLION)
TABLE 18. DNA SEQUENCING MARKET FOR CHAIN TERMINATION TECHNOLOGY, BY REGION, 20172025 ($MILLION)
TABLE 19. DNA SEQUENCING MARKET FOR NANOPORE SEQUENCING, BY REGION, 20172025 ($MILLION)
TABLE 20. GLOBAL DNA SEQUENCING MARKET, BY END USER, 20172025 ($MILLION)
TABLE 21. DNA SEQUENCING MARKET FOR ACADEMIC & GOVERNMENT RESEARCH INSTITUTE, BY REGION, 20172025 ($MILLION)
TABLE 22. DNA SEQUENCING MARKET FOR PHARMACEUTICAL COMAPNIES, BY REGION, 20172025 ($MILLION)
TABLE 23. DNA SEQUENCING MARKET FOR BIOTECHNOLOGY COMPANIES, BY REGION, 20172025 ($MILLION)
TABLE 24. DNA SEQUENCING MARKET FOR HOSPITAL AND CLINICS, BY REGION, 20172025 ($MILLION)
TABLE 25. DNA SEQUENCING MARKET REVENUE, BY REGION, 20172025 ($MILLION)
TABLE 26. NORTH AMERICA DNA SEQUENCING MARKET, BY COUNTRY, 20172025 ($MILLION)
TABLE 27. U.S. DNA SEQUENCING MARKET, BY PRODUCT, 20172025
TABLE 28. U.S. DNA SEQUENCING MARKET, BY APPLICATION, 20172025
TABLE 29. U.S. DNA SEQUENCING MARKET, BY TECHNOLOGY, 20172025
TABLE 30. U.S. DNA SEQUENCING MARKET, BY END USER, 20172025
TABLE 31. CANADA DNA SEQUENCING MARKET, BY PRODUCT, 20172025
TABLE 32. CANADA DNA SEQUENCING MARKET, BY APPLICATION, 20172025
TABLE 33. CANADA DNA SEQUENCING MARKET, BY TECHNOLOGY, 20172025
TABLE 34. CANADA DNA SEQUENCING MARKET, BY END USER, 20172025
TABLE 35. MEXICO DNA SEQUENCING MARKET, BY PRODUCT, 20172025
TABLE 36. MEXICO DNA SEQUENCING MARKET, BY APPLICATION, 20172025
TABLE 37. MEXICO DNA SEQUENCING MARKET, BY TECHNOLOGY, 20172025
TABLE 38. MEXICO DNA SEQUENCING MARKET, BY END USER, 20172025
TABLE 39. NORTH AMERICA DNA SEQUENCING MARKET, BY PRODUCT, 20172025 ($MILLION)
TABLE 40. NORTH AMERICA DNA SEQUENCING MARKET, BY APPLICATION, 20172025 ($MILLION)
TABLE 41. NORTH AMERICA DNA SEQUENCING MARKET, BY TECHNOLOGY, 20172025 ($MILLION)
TABLE 42. NORTH AMERICA DNA SEQUENCING MARKET, BY END USER, 20172025 ($MILLION)
TABLE 43. EUROPE DNA SEQUENCING MARKET, BY COUNTRY, 20172025 ($MILLION)
TABLE 44. GERMANY DNA SEQUENCING MARKET, BY PRODUCT, 20172025
TABLE 45. GERMANY DNA SEQUENCING MARKET, BY APPLICATION, 20172025
TABLE 46. GERMANY DNA SEQUENCING MARKET, BY TECHNOLOGY, 20172025
TABLE 47. GERMANY DNA SEQUENCING MARKET, BY END USER, 20172025
TABLE 48. FRANCE DNA SEQUENCING MARKET, BY PRODUCT, 20172025
TABLE 49. FRANCE DNA SEQUENCING MARKET, BY APPLICATION, 20172025
TABLE 50. FRANCE DNA SEQUENCING MARKET, BY TECHNOLOGY, 20172025
TABLE 51. FRANCE DNA SEQUENCING MARKET, BY END USER, 20172025
TABLE 52. UK DNA SEQUENCING MARKET, BY PRODUCT, 20172025
TABLE 53. UK DNA SEQUENCING MARKET, BY APPLICATION, 20172025
TABLE 54. UK DNA SEQUENCING MARKET, BY TECHNOLOGY, 20172025
TABLE 55. UK DNA SEQUENCING MARKET, BY END USER, 20172025
TABLE 56. ITALY DNA SEQUENCING MARKET, BY PRODUCT, 20172025
TABLE 57. ITALY DNA SEQUENCING MARKET, BY APPLICATION, 20172025
TABLE 58. ITALY DNA SEQUENCING MARKET, BY TECHNOLOGY, 20172025
TABLE 59. ITALY DNA SEQUENCING MARKET, BY END USER, 20172025
TABLE 60. SPAIN DNA SEQUENCING MARKET, BY PRODUCT, 20172025
TABLE 61. SPAIN DNA SEQUENCING MARKET, BY APPLICATION, 20172025
TABLE 62. SPAIN DNA SEQUENCING MARKET, BY TECHNOLOGY, 20172025
TABLE 63. SPAIN DNA SEQUENCING MARKET, BY END USER, 20172025
TABLE 64. REST OF EUROPE DNA SEQUENCING MARKET, BY PRODUCT, 20172025
TABLE 65. REST OF EUROPE DNA SEQUENCING MARKET, BY APPLICATION, 20172025
TABLE 66. REST OF EUROPE DNA SEQUENCING MARKET, BY TECHNOLOGY, 20172025
TABLE 67. REST OF EUROPE DNA SEQUENCING MARKET, BY END USER, 20172025
TABLE 68. EUROPE DNA SEQUENCING MARKET, BY PRODUCT, 20172025 ($MILLION)
TABLE 69. EUROPE DNA SEQUENCING MARKET, BY APPLICATION, 20172025 ($MILLION)
TABLE 70. EUROPE DNA SEQUENCING MARKET, BY TECHNOLOGY, 20172025 ($MILLION)
TABLE 71. EUROPE DNA SEQUENCING MARKET, BY END USER, 20172025 ($MILLION)
TABLE 72. ASIA-PACIFIC DNA SEQUENCING MARKET, BY COUNTRY, 20172025 ($MILLION)
TABLE 73. JAPAN DNA SEQUENCING MARKET, BY PRODUCT, 20172025
TABLE 74. JAPAN DNA SEQUENCING MARKET, BY APPLICATION, 20172025
TABLE 75. JAPAN DNA SEQUENCING MARKET, BY TECHNOLOGY, 20172025
TABLE 76. JAPAN DNA SEQUENCING MARKET, BY END USER, 20172025
TABLE 77. CHINA DNA SEQUENCING MARKET, BY PRODUCT, 20172025
TABLE 78. CHINA DNA SEQUENCING MARKET, BY APPLICATION, 20172025
TABLE 79. CHINA DNA SEQUENCING MARKET, BY TECHNOLOGY, 20172025
TABLE 80. CHINA DNA SEQUENCING MARKET, BY END USER, 20172025
TABLE 81. AUSTRALIA DNA SEQUENCING MARKET, BY PRODUCT, 20172025
TABLE 82. AUSTRALIA DNA SEQUENCING MARKET, BY APPLICATION, 20172025
TABLE 83. AUSTRALIA DNA SEQUENCING MARKET, BY TECHNOLOGY, 20172025
TABLE 84. AUSTRALIA DNA SEQUENCING MARKET, BY END USER, 20172025
TABLE 85. INDIA DNA SEQUENCING MARKET, BY PRODUCT, 20172025
TABLE 86. INDIA DNA SEQUENCING MARKET, BY APPLICATION, 20172025
TABLE 87. INDIA DNA SEQUENCING MARKET, BY TECHNOLOGY, 20172025
TABLE 88. INDIA DNA SEQUENCING MARKET, BY END USER, 20172025
TABLE 89. SOUTH KOREA DNA SEQUENCING MARKET, BY PRODUCT, 20172025
TABLE 90. SOUTH KOREA DNA SEQUENCING MARKET, BY APPLICATION, 20172025
TABLE 91. SOUTH KOREA DNA SEQUENCING MARKET, BY TECHNOLOGY, 20172025
TABLE 92. SOUTH KOREA DNA SEQUENCING MARKET, BY END USER, 20172025
TABLE 93. TAIWAN DNA SEQUENCING MARKET, BY PRODUCT, 20172025
TABLE 94. TAIWAN DNA SEQUENCING MARKET, BY APPLICATION, 20172025
TABLE 95. TAIWAN DNA SEQUENCING MARKET, BY TECHNOLOGY, 20172025
TABLE 96. TAIWAN DNA SEQUENCING MARKET, BY END USER, 20172025
TABLE 97. REST OF ASIA-PACIFIC DNA SEQUENCING MARKET, BY PRODUCT, 20172025
TABLE 98. REST OF ASIA-PACIFIC DNA SEQUENCING MARKET, BY APPLICATION, 20172025
TABLE 99. REST OF ASIA-PACIFIC DNA SEQUENCING MARKET, BY TECHNOLOGY, 20172025
TABLE 100. REST OF ASIA-PACIFIC DNA SEQUENCING MARKET, BY END USER, 20172025
TABLE 101. ASIA-PACIFIC DNA SEQUENCING MARKET, BY PRODUCT, 20172025 ($MILLION)
TABLE 102. ASIA-PACIFIC DNA SEQUENCING MARKET, BY APPLICATION, 20172025 ($MILLION)
TABLE 103. ASIA-PACIFIC DNA SEQUENCING MARKET, BY TECHNOLOGY, 20172025 ($MILLION)
TABLE 104. ASIA-PACIFIC DNA SEQUENCING MARKET, BY END USER, 20172025 ($MILLION)
TABLE 105. LAMEA DNA SEQUENCING MARKET, BY COUNTRY, 20172025 ($MILLION)
TABLE 106. BRAZIL DNA SEQUENCING MARKET, BY PRODUCT, 20172025
TABLE 107. BRAZIL DNA SEQUENCING MARKET, BY APPLICATION, 20172025
TABLE 108. BRAZIL DNA SEQUENCING MARKET, BY TECHNOLOGY, 20172025
TABLE 109. BRAZIL DNA SEQUENCING MARKET, BY END USER, 20172025
TABLE 110. TURKEY DNA SEQUENCING MARKET, BY PRODUCT, 20172025
TABLE 111. TURKEY DNA SEQUENCING MARKET, BY APPLICATION, 20172025
TABLE 112. TURKEY DNA SEQUENCING MARKET, BY TECHNOLOGY, 20172025
TABLE 113. TURKEY DNA SEQUENCING MARKET, BY END USER, 20172025
TABLE 114. SAUDI ARABIA DNA SEQUENCING MARKET, BY PRODUCT, 20172025
TABLE 115. SAUDI ARABIA DNA SEQUENCING MARKET, BY APPLICATION, 20172025
TABLE 116. SAUDI ARABIA DNA SEQUENCING MARKET, BY TECHNOLOGY, 20172025
TABLE 117. SAUDI ARABIA DNA SEQUENCING MARKET, BY END USER, 20172025
TABLE 118. REST OF LAMEA DNA SEQUENCING MARKET, BY PRODUCT, 20172025
TABLE 119. REST OF LAMEA DNA SEQUENCING MARKET, BY APPLICATION, 20172025
TABLE 120. REST OF LAMEA DNA SEQUENCING MARKET, BY TECHNOLOGY, 20172025
TABLE 121. BRAZIL DNA SEQUENCING MARKET, BY END USER, 20172025
TABLE 122. LAMEA DNA SEQUENCING MARKET, BY PRODUCT, 20172025 ($MILLION)
TABLE 123. LAMEA DNA SEQUENCING MARKET, BY APPLICATION, 20172025 ($MILLION)
TABLE 124. LAMEA DNA SEQUENCING MARKET, BY TECHNOLOGY, 20172025 ($MILLION)
TABLE 125. LAMEA DNA SEQUENCING MARKET, BY END USER, 20172025 ($MILLION)
TABLE 126. ABBOTT: COMPANY SNAPSHOT
TABLE 127. ABBOTT: OPERATING SEGMENTS
TABLE 128. ABBOTT: PRODUCT PORTFOLIO
TABLE 129. AGILENT: COMPANY SNAPSHOT
TABLE 130. AGILENT: OPERATING SEGMENTS
TABLE 131. BD : PRODUCT PORTFOLIO
TABLE 132. DANAHER: COMPANY SNAPSHOT
TABLE 133. DANAHER: OPERATING SEGMENTS
TABLE 134. DANAHER: PRODUCT PORTFOLIO
TABLE 135. ROCHE: COMPANY SNAPSHOT
TABLE 136. ROCHE: OPERATING SEGMENTS
TABLE 137. ROCHE: PRODUCT PORTFOLIO
TABLE 138. ILLUMINA: COMPANY SNAPSHOT
TABLE 139. ILLUMINA: OPERATING SEGMENTS
TABLE 140. ILLUMINA: PRODUCT PORTFOLIO
TABLE 141. LI-COR, INC.: COMPANY SNAPSHOT
TABLE 142. LI-COR, INC.: OPERATING SEGMENTS
TABLE 143. LI-COR, INC.: PRODUCT PORTFOLIO
TABLE 144. PACBIO: COMPANY SNAPSHOT
TABLE 145. PACBIO: PRODUCT PORTFOLIO
TABLE 146. PERKINELMER: COMPANY SNAPSHOT
TABLE 147. PERKINELMER: OPERATING SEGMENTS
TABLE 148. PERKINELMER: PRODUCT PORTFOLIO
TABLE 149. SEIMENS: COMPANY SNAPSHOT
TABLE 150. SEIMENS: PRODUCT SEGMENTS
TABLE 151. SEIMENS: PRODUCT PORTFOLIO
TABLE 152. THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT
TABLE 153. THERMO FISHER SCIENTIFIC: OPERATING SEGMENTS
TABLE 154. THERMO FISHER SCIENTIFIC: PRODUCT PORTFOLIO
TABLE 01. GLOBAL DNA SEQUENCING MARKET, BY PRODUCT, 20172025 ($MILLION)
TABLE 02. DNA SEQUENCING MARKET FOR CONSUMABLES, BY REGION, 20162023 ($MILLION)
TABLE 03. DNA SEQUENCING MARKET FOR INSTRUMENTS, BY REGION, 20172025 ($MILLION)
TABLE 04. DNA SEQUENCING MARKET FOR SERVICES, BY REGION, 20172025 ($MILLION)
TABLE 05. GLOBAL DNA SEQUENCING MARKET, BY INDICATION, 20172025 ($MILLION)
TABLE 06. DNA SEQUENCING MARKET FOR BIOMARKER AND CANCER, BY REGION, 20172025 ($MILLION)
TABLE 07. DNA SEQUENCING MARKET FOR DIAGNOSTICS, BY REGION, 20172025 ($MILLION)
TABLE 08. DNA SEQUENCING MARKET FOR REPRODUCTIVE HEALTH, BY REGION, 20172025 ($MILLION)
TABLE 09. DNA SEQUENCING MARKET FOR PERSONALIZED MEDICINE, BY REGION, 20172025 ($MILLION)
TABLE 10. DNA SEQUENCING MARKET FOR FORENSICS, BY REGION, 20172025 ($MILLION)
TABLE 11. DNA SEQUENCING MARKET FOR OTHER APPLICATIONS, BY REGION, 20172025 ($MILLION)
TABLE 12. GLOBAL DNA SEQUENCING MARKET, BY TECHNOLOGY, 20172025 ($MILLION)
TABLE 13. DNA SEQUENCING MARKET FOR SEQUENCING BY SYNTHESIS, BY REGION, 20172025 ($MILLION)
TABLE 14. DNA SEQUENCING MARKET FOR ION SEMICONDUCTOR SEQUENCING, BY REGION, 20172025 ($MILLION)
TABLE 15. DNA SEQUENCING MARKET FOR SEQUENCING BY LIGATION, BY REGION, 20172025 ($MILLION)
TABLE 16. DNA SEQUENCING MARKET FOR PYROSEQUENCING, BY REGION, 20172025 ($MILLION)
TABLE 17. DNA SEQUENCING MARKET FOR SINGLE-MOLECULE REAL-TIME SEQUENCING, BY REGION, 20172025 ($MILLION)
TABLE 18. DNA SEQUENCING MARKET FOR CHAIN TERMINATION TECHNOLOGY, BY REGION, 20172025 ($MILLION)
TABLE 19. DNA SEQUENCING MARKET FOR NANOPORE SEQUENCING, BY REGION, 20172025 ($MILLION)
TABLE 20. GLOBAL DNA SEQUENCING MARKET, BY END USER, 20172025 ($MILLION)
TABLE 21. DNA SEQUENCING MARKET FOR ACADEMIC & GOVERNMENT RESEARCH INSTITUTE, BY REGION, 20172025 ($MILLION)
TABLE 22. DNA SEQUENCING MARKET FOR PHARMACEUTICAL COMAPNIES, BY REGION, 20172025 ($MILLION)
TABLE 23. DNA SEQUENCING MARKET FOR BIOTECHNOLOGY COMPANIES, BY REGION, 20172025 ($MILLION)
TABLE 24. DNA SEQUENCING MARKET FOR HOSPITAL AND CLINICS, BY REGION, 20172025 ($MILLION)
TABLE 25. DNA SEQUENCING MARKET REVENUE, BY REGION, 20172025 ($MILLION)
TABLE 26. NORTH AMERICA DNA SEQUENCING MARKET, BY COUNTRY, 20172025 ($MILLION)
TABLE 27. U.S. DNA SEQUENCING MARKET, BY PRODUCT, 20172025
TABLE 28. U.S. DNA SEQUENCING MARKET, BY APPLICATION, 20172025
TABLE 29. U.S. DNA SEQUENCING MARKET, BY TECHNOLOGY, 20172025
TABLE 30. U.S. DNA SEQUENCING MARKET, BY END USER, 20172025
TABLE 31. CANADA DNA SEQUENCING MARKET, BY PRODUCT, 20172025
TABLE 32. CANADA DNA SEQUENCING MARKET, BY APPLICATION, 20172025
TABLE 33. CANADA DNA SEQUENCING MARKET, BY TECHNOLOGY, 20172025
TABLE 34. CANADA DNA SEQUENCING MARKET, BY END USER, 20172025
TABLE 35. MEXICO DNA SEQUENCING MARKET, BY PRODUCT, 20172025
TABLE 36. MEXICO DNA SEQUENCING MARKET, BY APPLICATION, 20172025
TABLE 37. MEXICO DNA SEQUENCING MARKET, BY TECHNOLOGY, 20172025
TABLE 38. MEXICO DNA SEQUENCING MARKET, BY END USER, 20172025
TABLE 39. NORTH AMERICA DNA SEQUENCING MARKET, BY PRODUCT, 20172025 ($MILLION)
TABLE 40. NORTH AMERICA DNA SEQUENCING MARKET, BY APPLICATION, 20172025 ($MILLION)
TABLE 41. NORTH AMERICA DNA SEQUENCING MARKET, BY TECHNOLOGY, 20172025 ($MILLION)
TABLE 42. NORTH AMERICA DNA SEQUENCING MARKET, BY END USER, 20172025 ($MILLION)
TABLE 43. EUROPE DNA SEQUENCING MARKET, BY COUNTRY, 20172025 ($MILLION)
TABLE 44. GERMANY DNA SEQUENCING MARKET, BY PRODUCT, 20172025
TABLE 45. GERMANY DNA SEQUENCING MARKET, BY APPLICATION, 20172025
TABLE 46. GERMANY DNA SEQUENCING MARKET, BY TECHNOLOGY, 20172025
TABLE 47. GERMANY DNA SEQUENCING MARKET, BY END USER, 20172025
TABLE 48. FRANCE DNA SEQUENCING MARKET, BY PRODUCT, 20172025
TABLE 49. FRANCE DNA SEQUENCING MARKET, BY APPLICATION, 20172025
TABLE 50. FRANCE DNA SEQUENCING MARKET, BY TECHNOLOGY, 20172025
TABLE 51. FRANCE DNA SEQUENCING MARKET, BY END USER, 20172025
TABLE 52. UK DNA SEQUENCING MARKET, BY PRODUCT, 20172025
TABLE 53. UK DNA SEQUENCING MARKET, BY APPLICATION, 20172025
TABLE 54. UK DNA SEQUENCING MARKET, BY TECHNOLOGY, 20172025
TABLE 55. UK DNA SEQUENCING MARKET, BY END USER, 20172025
TABLE 56. ITALY DNA SEQUENCING MARKET, BY PRODUCT, 20172025
TABLE 57. ITALY DNA SEQUENCING MARKET, BY APPLICATION, 20172025
TABLE 58. ITALY DNA SEQUENCING MARKET, BY TECHNOLOGY, 20172025
TABLE 59. ITALY DNA SEQUENCING MARKET, BY END USER, 20172025
TABLE 60. SPAIN DNA SEQUENCING MARKET, BY PRODUCT, 20172025
TABLE 61. SPAIN DNA SEQUENCING MARKET, BY APPLICATION, 20172025
TABLE 62. SPAIN DNA SEQUENCING MARKET, BY TECHNOLOGY, 20172025
TABLE 63. SPAIN DNA SEQUENCING MARKET, BY END USER, 20172025
TABLE 64. REST OF EUROPE DNA SEQUENCING MARKET, BY PRODUCT, 20172025
TABLE 65. REST OF EUROPE DNA SEQUENCING MARKET, BY APPLICATION, 20172025
TABLE 66. REST OF EUROPE DNA SEQUENCING MARKET, BY TECHNOLOGY, 20172025
TABLE 67. REST OF EUROPE DNA SEQUENCING MARKET, BY END USER, 20172025
TABLE 68. EUROPE DNA SEQUENCING MARKET, BY PRODUCT, 20172025 ($MILLION)
TABLE 69. EUROPE DNA SEQUENCING MARKET, BY APPLICATION, 20172025 ($MILLION)
TABLE 70. EUROPE DNA SEQUENCING MARKET, BY TECHNOLOGY, 20172025 ($MILLION)
TABLE 71. EUROPE DNA SEQUENCING MARKET, BY END USER, 20172025 ($MILLION)
TABLE 72. ASIA-PACIFIC DNA SEQUENCING MARKET, BY COUNTRY, 20172025 ($MILLION)
TABLE 73. JAPAN DNA SEQUENCING MARKET, BY PRODUCT, 20172025
TABLE 74. JAPAN DNA SEQUENCING MARKET, BY APPLICATION, 20172025
TABLE 75. JAPAN DNA SEQUENCING MARKET, BY TECHNOLOGY, 20172025
TABLE 76. JAPAN DNA SEQUENCING MARKET, BY END USER, 20172025
TABLE 77. CHINA DNA SEQUENCING MARKET, BY PRODUCT, 20172025
TABLE 78. CHINA DNA SEQUENCING MARKET, BY APPLICATION, 20172025
TABLE 79. CHINA DNA SEQUENCING MARKET, BY TECHNOLOGY, 20172025
TABLE 80. CHINA DNA SEQUENCING MARKET, BY END USER, 20172025
TABLE 81. AUSTRALIA DNA SEQUENCING MARKET, BY PRODUCT, 20172025
TABLE 82. AUSTRALIA DNA SEQUENCING MARKET, BY APPLICATION, 20172025
TABLE 83. AUSTRALIA DNA SEQUENCING MARKET, BY TECHNOLOGY, 20172025
TABLE 84. AUSTRALIA DNA SEQUENCING MARKET, BY END USER, 20172025
TABLE 85. INDIA DNA SEQUENCING MARKET, BY PRODUCT, 20172025
TABLE 86. INDIA DNA SEQUENCING MARKET, BY APPLICATION, 20172025
TABLE 87. INDIA DNA SEQUENCING MARKET, BY TECHNOLOGY, 20172025
TABLE 88. INDIA DNA SEQUENCING MARKET, BY END USER, 20172025
TABLE 89. SOUTH KOREA DNA SEQUENCING MARKET, BY PRODUCT, 20172025
TABLE 90. SOUTH KOREA DNA SEQUENCING MARKET, BY APPLICATION, 20172025
TABLE 91. SOUTH KOREA DNA SEQUENCING MARKET, BY TECHNOLOGY, 20172025
TABLE 92. SOUTH KOREA DNA SEQUENCING MARKET, BY END USER, 20172025
TABLE 93. TAIWAN DNA SEQUENCING MARKET, BY PRODUCT, 20172025
TABLE 94. TAIWAN DNA SEQUENCING MARKET, BY APPLICATION, 20172025
TABLE 95. TAIWAN DNA SEQUENCING MARKET, BY TECHNOLOGY, 20172025
TABLE 96. TAIWAN DNA SEQUENCING MARKET, BY END USER, 20172025
TABLE 97. REST OF ASIA-PACIFIC DNA SEQUENCING MARKET, BY PRODUCT, 20172025
TABLE 98. REST OF ASIA-PACIFIC DNA SEQUENCING MARKET, BY APPLICATION, 20172025
TABLE 99. REST OF ASIA-PACIFIC DNA SEQUENCING MARKET, BY TECHNOLOGY, 20172025
TABLE 100. REST OF ASIA-PACIFIC DNA SEQUENCING MARKET, BY END USER, 20172025
TABLE 101. ASIA-PACIFIC DNA SEQUENCING MARKET, BY PRODUCT, 20172025 ($MILLION)
TABLE 102. ASIA-PACIFIC DNA SEQUENCING MARKET, BY APPLICATION, 20172025 ($MILLION)
TABLE 103. ASIA-PACIFIC DNA SEQUENCING MARKET, BY TECHNOLOGY, 20172025 ($MILLION)
TABLE 104. ASIA-PACIFIC DNA SEQUENCING MARKET, BY END USER, 20172025 ($MILLION)
TABLE 105. LAMEA DNA SEQUENCING MARKET, BY COUNTRY, 20172025 ($MILLION)
TABLE 106. BRAZIL DNA SEQUENCING MARKET, BY PRODUCT, 20172025
TABLE 107. BRAZIL DNA SEQUENCING MARKET, BY APPLICATION, 20172025
TABLE 108. BRAZIL DNA SEQUENCING MARKET, BY TECHNOLOGY, 20172025
TABLE 109. BRAZIL DNA SEQUENCING MARKET, BY END USER, 20172025
TABLE 110. TURKEY DNA SEQUENCING MARKET, BY PRODUCT, 20172025
TABLE 111. TURKEY DNA SEQUENCING MARKET, BY APPLICATION, 20172025
TABLE 112. TURKEY DNA SEQUENCING MARKET, BY TECHNOLOGY, 20172025
TABLE 113. TURKEY DNA SEQUENCING MARKET, BY END USER, 20172025
TABLE 114. SAUDI ARABIA DNA SEQUENCING MARKET, BY PRODUCT, 20172025
TABLE 115. SAUDI ARABIA DNA SEQUENCING MARKET, BY APPLICATION, 20172025
TABLE 116. SAUDI ARABIA DNA SEQUENCING MARKET, BY TECHNOLOGY, 20172025
TABLE 117. SAUDI ARABIA DNA SEQUENCING MARKET, BY END USER, 20172025
TABLE 118. REST OF LAMEA DNA SEQUENCING MARKET, BY PRODUCT, 20172025
TABLE 119. REST OF LAMEA DNA SEQUENCING MARKET, BY APPLICATION, 20172025
TABLE 120. REST OF LAMEA DNA SEQUENCING MARKET, BY TECHNOLOGY, 20172025
TABLE 121. BRAZIL DNA SEQUENCING MARKET, BY END USER, 20172025
TABLE 122. LAMEA DNA SEQUENCING MARKET, BY PRODUCT, 20172025 ($MILLION)
TABLE 123. LAMEA DNA SEQUENCING MARKET, BY APPLICATION, 20172025 ($MILLION)
TABLE 124. LAMEA DNA SEQUENCING MARKET, BY TECHNOLOGY, 20172025 ($MILLION)
TABLE 125. LAMEA DNA SEQUENCING MARKET, BY END USER, 20172025 ($MILLION)
TABLE 126. ABBOTT: COMPANY SNAPSHOT
TABLE 127. ABBOTT: OPERATING SEGMENTS
TABLE 128. ABBOTT: PRODUCT PORTFOLIO
TABLE 129. AGILENT: COMPANY SNAPSHOT
TABLE 130. AGILENT: OPERATING SEGMENTS
TABLE 131. BD : PRODUCT PORTFOLIO
TABLE 132. DANAHER: COMPANY SNAPSHOT
TABLE 133. DANAHER: OPERATING SEGMENTS
TABLE 134. DANAHER: PRODUCT PORTFOLIO
TABLE 135. ROCHE: COMPANY SNAPSHOT
TABLE 136. ROCHE: OPERATING SEGMENTS
TABLE 137. ROCHE: PRODUCT PORTFOLIO
TABLE 138. ILLUMINA: COMPANY SNAPSHOT
TABLE 139. ILLUMINA: OPERATING SEGMENTS
TABLE 140. ILLUMINA: PRODUCT PORTFOLIO
TABLE 141. LI-COR, INC.: COMPANY SNAPSHOT
TABLE 142. LI-COR, INC.: OPERATING SEGMENTS
TABLE 143. LI-COR, INC.: PRODUCT PORTFOLIO
TABLE 144. PACBIO: COMPANY SNAPSHOT
TABLE 145. PACBIO: PRODUCT PORTFOLIO
TABLE 146. PERKINELMER: COMPANY SNAPSHOT
TABLE 147. PERKINELMER: OPERATING SEGMENTS
TABLE 148. PERKINELMER: PRODUCT PORTFOLIO
TABLE 149. SEIMENS: COMPANY SNAPSHOT
TABLE 150. SEIMENS: PRODUCT SEGMENTS
TABLE 151. SEIMENS: PRODUCT PORTFOLIO
TABLE 152. THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT
TABLE 153. THERMO FISHER SCIENTIFIC: OPERATING SEGMENTS
TABLE 154. THERMO FISHER SCIENTIFIC: PRODUCT PORTFOLIO
LIST OF FIGURES
FIGURE 01. GLOBAL DNA SEQUENCING MARKET SEGMENTATION
FIGURE 02. TOP INVESTMENT POCKETS
FIGURE 03. TOP WINNING STRATEGIES, BY YEAR, 20142018
FIGURE 04. TOP WINNING STRATEGIES, 20142018
FIGURE 05. TOP WINNING STRATEGIES: NATURE AND TYPE, 20142018
FIGURE 06. GLOBAL DNA SEQUENCING MARKET, MARKET SHARE ANALYSIS, 2017
FIGURE 07. NORTH AMERICA DNA SEQUENCING MARKET, MARKET SHARE ANALYSIS, 2017
FIGURE 08. EUROPE DNA SEQUENCING MARKET, MARKET SHARE ANALYSIS, 2017
FIGURE 09. ASIA-PACIFIC DNA SEQUENCING MARKET, MARKET SHARE ANALYSIS, 2017
FIGURE 10. U.S. DNA SEQUENCING MARKET, MARKET SHARE ANALYSIS, 2017
FIGURE 11. UK DNA SEQUENCING MARKET, MARKET SHARE ANALYSIS, 2017
FIGURE 12. GERMANY DNA SEQUENCING MARKET, MARKET SHARE ANALYSIS, 2017
FIGURE 13. AUSTRIA DNA SEQUENCING MARKET, MARKET SHARE ANALYSIS, 2017
FIGURE 14. CHINA DNA SEQUENCING MARKET, MARKET SHARE ANALYSIS, 2017
FIGURE 15. SINGAPORE DNA SEQUENCING MARKET, MARKET SHARE ANALYSIS, 2017
FIGURE 16. PATENTS ANALYSIS, BY REGION, 20152018
FIGURE 17. PATENTS ANALYSIS, BY YEAR, 20152018
FIGURE 18. HIGH BARGANING POWER OF BUYERS
FIGURE 19. MODERATE BARGANING POWER OF SUPPLIERS
FIGURE 20. MODERATE THREAT OF SUBSTITUTION
FIGURE 21. MODERATE THREAT OF NEW ENTRANTS
FIGURE 22. MODERATE COMPETITIVE RIVALRY
FIGURE 23. IMPACT ANALYSES
FIGURE 24. COMPARATIVE ANALYSIS OF DNA SEQUENCING MARKET FOR CONSUMABLES, BY COUNTRY, 2017 & 2025
FIGURE 25. COMPARATIVE ANALYSIS OF DNA SEQUENCING MARKET FOR INSTRUMENTS, BY COUNTRY, 2017 & 2025
FIGURE 26. COMPARATIVE ANALYSIS OF DNA SEQUENCING MARKET FOR SERVICES, BY COUNTRY, 2017 & 2025
FIGURE 27. COMPARATIVE ANALYSIS OF DNA SEQUENCING MARKET FOR BIOMARKET AND CANCER, BY COUNTRY, 2017 & 2025
FIGURE 28. COMPARATIVE ANALYSIS OF DNA SEQUENCING MARKET FOR DIAGNOSTICS, BY COUNTRY, 2017 & 2025
FIGURE 29. COMPARATIVE ANALYSIS OF DNA SEQUENCING MARKET FOR REPRODUCTIVE HEALTH, BY COUNTRY, 2017 & 2025
FIGURE 30. COMPARATIVE ANALYSIS OF DNA SEQUENCING MARKET FOR PERSONALIZED MEDICINE, BY COUNTRY, 2017 & 2025
FIGURE 31. COMPARATIVE ANALYSIS OF DNA SEQUENCING MARKET FOR FORENSICS, BY COUNTRY, 2017 & 2025
FIGURE 32. COMPARATIVE ANALYSIS OF DNA SEQUENCING MARKET FOR OTHERS, BY COUNTRY, 2017 & 2025
FIGURE 33. COMPARATIVE ANALYSIS OF DNA SEQUENCING MARKET FOR SYNTHESIS BY SEQUENCING, BY COUNTRY, 2017 & 2025
FIGURE 34. COMPARATIVE ANALYSIS OF DNA SEQUENCING MARKET FOR ION SEMICONDUCTOR SEQUENCING, BY COUNTRY, 2017 & 2025
FIGURE 35. COMPARATIVE ANALYSIS OF DNA SEQUENCING MARKET FOR SEQUENCING BY LIGATION, BY COUNTRY, 2017 & 2025
FIGURE 36. COMPARATIVE ANALYSIS OF DNA SEQUENCING MARKET FOR PYROSEQUENCING, BY COUNTRY, 2017 & 2025
FIGURE 37. COMPARATIVE ANALYSIS OF DNA SEQUENCING MARKET FOR SINGLE-MOLECULE REAL-TIME SEQUENCING, BY COUNTRY, 2017 & 2025
FIGURE 38. COMPARATIVE ANALYSIS OF DNA SEQUENCING MARKET FOR CHAIN TERMINATION TECHNOLOGY, BY COUNTRY, 2017 & 2025
FIGURE 39. COMPARATIVE ANALYSIS OF DNA SEQUENCING MARKET FOR NANOPORE SEQUENCING, BY COUNTRY, 2017 & 2025
FIGURE 40. COMPARATIVE ANALYSIS OF DNA SEQUENCING MARKET FOR ACADEMIC & GOVERNMENT RESEARCH INSTITUTE, BY COUNTRY, 2017 & 2025
FIGURE 41. COMPARATIVE ANALYSIS OF DNA SEQUENCING MARKET FOR PHARMACEUTICAL COMPANIES, BY COUNTRY, 2017 & 2025
FIGURE 42. COMPARATIVE ANALYSIS OF DNA SEQUENCING MARKET FOR BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2017 & 2025
FIGURE 43. COMPARATIVE ANALYSIS OF DNA SEQUENCING MARKET FOR HOSPITAL AND CLINICS, BY COUNTRY, 2017 & 2025
FIGURE 44. ABBOTT: NET SALES, 20152017 ($MILLION)
FIGURE 45. ABBOTT: NET SALES SHARE, BY OPERATING SEGMENT, 2017 (%)
FIGURE 46. ABBOTT: NET SALES SHARE, BY REGION, 2017 (%)
FIGURE 47. AGILENT: REVENUE, 20152017 ($MILLION)
FIGURE 48. AGILENT: REVENUE SHARE BY OPERATING SEGMENT, 2017 (%)
FIGURE 49. AGILENT: REVENUE SHARE BY REGION, 2017 (%)
FIGURE 50. DANAHER: NET SALES, 20152017 ($MILLION)
FIGURE 51. DANAHER: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 52. DANAHER: REVENUE SHARE BY REGION, 2017 (%)
FIGURE 53. ROCHE: NET SALES, 20152017 ($MILLION)
FIGURE 54. ROCHE: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 55. ROCHE: REVENUE SHARE BY REGION, 2017 (%)
FIGURE 56. ILLUMINA: REVENUE, 20152017 ($MILLION)
FIGURE 57. ILLUMINA: REVENUE SHARE BY OPERATING SEGMENT, 2017 (%)
FIGURE 58. ILLUMINA: REVENUE SHARE BY REGION, 2017 (%)
FIGURE 59. PACBIO: REVENUE, 20152017 ($MILLION)
FIGURE 60. PACBIO: REVENUE SHARE BY REGION, 2017 (%)
FIGURE 61. PERKINELMER: NET SALES, 20152017 ($MILLION)
FIGURE 62. PERKINELMER: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 63. PERKINELMER: REVENUE SHARE BY REGION, 2017 (%)
FIGURE 64. SEIMENS: NET SALES, 20152017 ($MILLION)
FIGURE 65. SEIMENS: REVENUE SHARE BY PRODUCT SEGMENT, 2017 (%)
FIGURE 66. SEIMENS: REVENUE SHARE BY REGION, 2017 (%)
FIGURE 67. THERMO FISHER SCIENTIFIC: REVENUE, 20152017 ($MILLION)
FIGURE 68. THERMO FISHER SCIENTIFIC: REVENUE SHARE, BY SEGMENT, 2017 (%)
FIGURE 69. THERMO FISHER SCIENTIFIC: REVENUE SHARE, BY REGION, 2017 (%)
FIGURE 01. GLOBAL DNA SEQUENCING MARKET SEGMENTATION
FIGURE 02. TOP INVESTMENT POCKETS
FIGURE 03. TOP WINNING STRATEGIES, BY YEAR, 20142018
FIGURE 04. TOP WINNING STRATEGIES, 20142018
FIGURE 05. TOP WINNING STRATEGIES: NATURE AND TYPE, 20142018
FIGURE 06. GLOBAL DNA SEQUENCING MARKET, MARKET SHARE ANALYSIS, 2017
FIGURE 07. NORTH AMERICA DNA SEQUENCING MARKET, MARKET SHARE ANALYSIS, 2017
FIGURE 08. EUROPE DNA SEQUENCING MARKET, MARKET SHARE ANALYSIS, 2017
FIGURE 09. ASIA-PACIFIC DNA SEQUENCING MARKET, MARKET SHARE ANALYSIS, 2017
FIGURE 10. U.S. DNA SEQUENCING MARKET, MARKET SHARE ANALYSIS, 2017
FIGURE 11. UK DNA SEQUENCING MARKET, MARKET SHARE ANALYSIS, 2017
FIGURE 12. GERMANY DNA SEQUENCING MARKET, MARKET SHARE ANALYSIS, 2017
FIGURE 13. AUSTRIA DNA SEQUENCING MARKET, MARKET SHARE ANALYSIS, 2017
FIGURE 14. CHINA DNA SEQUENCING MARKET, MARKET SHARE ANALYSIS, 2017
FIGURE 15. SINGAPORE DNA SEQUENCING MARKET, MARKET SHARE ANALYSIS, 2017
FIGURE 16. PATENTS ANALYSIS, BY REGION, 20152018
FIGURE 17. PATENTS ANALYSIS, BY YEAR, 20152018
FIGURE 18. HIGH BARGANING POWER OF BUYERS
FIGURE 19. MODERATE BARGANING POWER OF SUPPLIERS
FIGURE 20. MODERATE THREAT OF SUBSTITUTION
FIGURE 21. MODERATE THREAT OF NEW ENTRANTS
FIGURE 22. MODERATE COMPETITIVE RIVALRY
FIGURE 23. IMPACT ANALYSES
FIGURE 24. COMPARATIVE ANALYSIS OF DNA SEQUENCING MARKET FOR CONSUMABLES, BY COUNTRY, 2017 & 2025
FIGURE 25. COMPARATIVE ANALYSIS OF DNA SEQUENCING MARKET FOR INSTRUMENTS, BY COUNTRY, 2017 & 2025
FIGURE 26. COMPARATIVE ANALYSIS OF DNA SEQUENCING MARKET FOR SERVICES, BY COUNTRY, 2017 & 2025
FIGURE 27. COMPARATIVE ANALYSIS OF DNA SEQUENCING MARKET FOR BIOMARKET AND CANCER, BY COUNTRY, 2017 & 2025
FIGURE 28. COMPARATIVE ANALYSIS OF DNA SEQUENCING MARKET FOR DIAGNOSTICS, BY COUNTRY, 2017 & 2025
FIGURE 29. COMPARATIVE ANALYSIS OF DNA SEQUENCING MARKET FOR REPRODUCTIVE HEALTH, BY COUNTRY, 2017 & 2025
FIGURE 30. COMPARATIVE ANALYSIS OF DNA SEQUENCING MARKET FOR PERSONALIZED MEDICINE, BY COUNTRY, 2017 & 2025
FIGURE 31. COMPARATIVE ANALYSIS OF DNA SEQUENCING MARKET FOR FORENSICS, BY COUNTRY, 2017 & 2025
FIGURE 32. COMPARATIVE ANALYSIS OF DNA SEQUENCING MARKET FOR OTHERS, BY COUNTRY, 2017 & 2025
FIGURE 33. COMPARATIVE ANALYSIS OF DNA SEQUENCING MARKET FOR SYNTHESIS BY SEQUENCING, BY COUNTRY, 2017 & 2025
FIGURE 34. COMPARATIVE ANALYSIS OF DNA SEQUENCING MARKET FOR ION SEMICONDUCTOR SEQUENCING, BY COUNTRY, 2017 & 2025
FIGURE 35. COMPARATIVE ANALYSIS OF DNA SEQUENCING MARKET FOR SEQUENCING BY LIGATION, BY COUNTRY, 2017 & 2025
FIGURE 36. COMPARATIVE ANALYSIS OF DNA SEQUENCING MARKET FOR PYROSEQUENCING, BY COUNTRY, 2017 & 2025
FIGURE 37. COMPARATIVE ANALYSIS OF DNA SEQUENCING MARKET FOR SINGLE-MOLECULE REAL-TIME SEQUENCING, BY COUNTRY, 2017 & 2025
FIGURE 38. COMPARATIVE ANALYSIS OF DNA SEQUENCING MARKET FOR CHAIN TERMINATION TECHNOLOGY, BY COUNTRY, 2017 & 2025
FIGURE 39. COMPARATIVE ANALYSIS OF DNA SEQUENCING MARKET FOR NANOPORE SEQUENCING, BY COUNTRY, 2017 & 2025
FIGURE 40. COMPARATIVE ANALYSIS OF DNA SEQUENCING MARKET FOR ACADEMIC & GOVERNMENT RESEARCH INSTITUTE, BY COUNTRY, 2017 & 2025
FIGURE 41. COMPARATIVE ANALYSIS OF DNA SEQUENCING MARKET FOR PHARMACEUTICAL COMPANIES, BY COUNTRY, 2017 & 2025
FIGURE 42. COMPARATIVE ANALYSIS OF DNA SEQUENCING MARKET FOR BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2017 & 2025
FIGURE 43. COMPARATIVE ANALYSIS OF DNA SEQUENCING MARKET FOR HOSPITAL AND CLINICS, BY COUNTRY, 2017 & 2025
FIGURE 44. ABBOTT: NET SALES, 20152017 ($MILLION)
FIGURE 45. ABBOTT: NET SALES SHARE, BY OPERATING SEGMENT, 2017 (%)
FIGURE 46. ABBOTT: NET SALES SHARE, BY REGION, 2017 (%)
FIGURE 47. AGILENT: REVENUE, 20152017 ($MILLION)
FIGURE 48. AGILENT: REVENUE SHARE BY OPERATING SEGMENT, 2017 (%)
FIGURE 49. AGILENT: REVENUE SHARE BY REGION, 2017 (%)
FIGURE 50. DANAHER: NET SALES, 20152017 ($MILLION)
FIGURE 51. DANAHER: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 52. DANAHER: REVENUE SHARE BY REGION, 2017 (%)
FIGURE 53. ROCHE: NET SALES, 20152017 ($MILLION)
FIGURE 54. ROCHE: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 55. ROCHE: REVENUE SHARE BY REGION, 2017 (%)
FIGURE 56. ILLUMINA: REVENUE, 20152017 ($MILLION)
FIGURE 57. ILLUMINA: REVENUE SHARE BY OPERATING SEGMENT, 2017 (%)
FIGURE 58. ILLUMINA: REVENUE SHARE BY REGION, 2017 (%)
FIGURE 59. PACBIO: REVENUE, 20152017 ($MILLION)
FIGURE 60. PACBIO: REVENUE SHARE BY REGION, 2017 (%)
FIGURE 61. PERKINELMER: NET SALES, 20152017 ($MILLION)
FIGURE 62. PERKINELMER: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 63. PERKINELMER: REVENUE SHARE BY REGION, 2017 (%)
FIGURE 64. SEIMENS: NET SALES, 20152017 ($MILLION)
FIGURE 65. SEIMENS: REVENUE SHARE BY PRODUCT SEGMENT, 2017 (%)
FIGURE 66. SEIMENS: REVENUE SHARE BY REGION, 2017 (%)
FIGURE 67. THERMO FISHER SCIENTIFIC: REVENUE, 20152017 ($MILLION)
FIGURE 68. THERMO FISHER SCIENTIFIC: REVENUE SHARE, BY SEGMENT, 2017 (%)
FIGURE 69. THERMO FISHER SCIENTIFIC: REVENUE SHARE, BY REGION, 2017 (%)
